Effect of postremission high dose cytarabine-based consolidation chemotherapy before allogenic stem cell transplantation in outcomes of acute myeloid leukemia patients


CIFTCILER R., DEMİROĞLU H., BÜYÜKAŞIK Y., OKAY M., AKSU S., Sayinalp N., ...More

TRANSFUSION AND APHERESIS SCIENCE, vol.57, no.6, pp.752-755, 2018 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 57 Issue: 6
  • Publication Date: 2018
  • Doi Number: 10.1016/j.transci.2018.09.013
  • Journal Name: TRANSFUSION AND APHERESIS SCIENCE
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.752-755
  • Keywords: Acute myeloid leukemia, Allogeneic stem cell transplantation, High-Dose cytarabine, ACUTE MYELOGENOUS LEUKEMIA, MAINTENANCE CHEMOTHERAPY, REMISSION, THERAPY, ADULTS, DAUNORUBICIN, SURVIVAL

Abstract

Background and Aim: This is a retrospective study aiming to investigate the effect of the number of high dose cytarabine-based chemotherapy (HiDAC) courses in patients with acute myeloid leukemia before allogenic stem cell transplantation (ASCT).